Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring

Wound Repair and Regeneration

Volumn 21, Issue 1, 2013, Pages 55-65

  Rahmani Neishaboor, Elham ^a   Jallili, Reza ^a   Hartwell, Ryan ^a   Leung, Victor ^a   Carr, Nicholas ^a   Ghahary, Aziz ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARBOXYMETHYLCELLULOSE; COLLAGEN; INTERSTITIAL COLLAGENASE; STRATIFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; COLLAGEN SYNTHESIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; EMULGEL WOUND DRESSING; EXPERIMENTAL RABBIT; FIBROBLAST; HUMAN; HUMAN CELL; HYPERTROPHIC SCAR; IN VITRO STUDY; KERATINOCYTE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; WOUND DRESSING;

14-3-3 PROTEINS; ADMINISTRATION, CUTANEOUS; ANIMALS; ASPIRIN; BANDAGES; CICATRIX, HYPERTROPHIC; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; EXONUCLEASES; FIBROBLASTS; GELS; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 1; RABBITS; TUMOR MARKERS, BIOLOGICAL; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84872113803     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00857.x     Document Type: Article

References (40)

1. Tredget EE, Nedelec B, Scott PG, Ghahary A,. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 1997; 77: 701-730.
2. Aarabi S, Longaker MT, Gurtner GC,. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 2007; 4: e234.
3. Boutli-Kasapidou F, Tsakiri A, Anagnostou E, Mourellou O,. Hypertrophic and keloidal scars: an approach to polytherapy. Int J Dermatol 2005; 44: 324-327.
4. Mutalik S,. Treatment of keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol 2005; 71: 3-8.
5. Occleston NL, O'Kane S, Goldspink N, Ferguson MW,. New therapeutics for the prevention and reduction of scarring. Drug Discov Today 2008; 13: 973-981.
6. Ghahary A, Marcoux, Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M,. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 2004; 122: 1188-1197.
7. Ghaffari A, Li Y, Karami A, Ghaffari M, Tredget EE, Ghahary A,. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J Cell Biochem 2006; 98: 383-393.
8. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A,. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 2005; 125: 230-238.
9. Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I,. Matrix metalloproteinases in arthritic disease. Arthritis Res 2002; 4 (Suppl. 3): S39-49.
10. Stamenkovic I,. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003; 200: 448-464.
11. Nagase H, Woessner JF, Jr,. Matrix metalloproteinases. J Biol Chem 1999; 274: 21491-21494.
12. Niessen FB, Spauwen PH, Schalkwijk J, Kon M,. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104: 1435-1458.
13. Singer AJ, Clark RA,. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
14. Yang GP, Lim IJ, Phan TT, Lorenz HP, Longaker MT,. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen 2003; 11: 411-418.
15. Rahmani-Neishaboor E, Yau FM, Jalili R, Kilani RT, Ghahary A,. Improvement of hypertrophic scarring by using topical anti-fibrogenic/anti- inflammatory factors in a rabbit ear model. Wound Repair Regen 2010; 18: 401-408.
16. Guglielmini G,. Nanostructured novel carrier for topical application. Clin Dermatol 2008; 26: 341-346.
17. Sarker DK,. Engineering of nanoemulsions for drug delivery. Curr Drug Deliv 2005; 2: 297-310.
18. Rojanasakul Y, Wang LY, Bhat M, Glover DD, Malanga CJ, Ma JK,. The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res 1992; 9: 1029-1034.
19. Piemi MP, Korner D, Benita S, Marty JP,. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J Control Release 1999; 58: 177-187.
20. Hagigit T, Abdulrazik M, Orucov F, Valamanesh F, Hagedorn M, Lambert G, Behar-Cohen F, Benita S,. Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye. J Control Release 2010; 145: 297-305.
21. Sznitowska M, Janicki S, Zurowska-Pryczkowska K, Mackiewicz J,. In vivo evaluation of submicron emulsions with pilocarpine: the effect of pH and chemical form of the drug. J Microencapsul 2001; 18: 173-181.
22. Bivas-Benita M, Oudshoorn M, Romeijn S, Van, Meijgaarden K, Koerten H, van der, Meulen H, Lambert G, Ottenhoff T, Benita S, Junginger H, Borchard G,. Cationic submicron emulsions for pulmonary DNA immunization. J Control Release 2004; 100: 145-155.
23. Shi R, Hong L, Wu D, Ning X, Chen Y, Lin T, Fan D, Wu K,. Enhanced immune response to gastric cancer specific antigen peptide by coencapsulation with CpG oligodeoxynucleotides in nanoemulsion. Cancer Biol Ther 2005; 4: 218-224.
24. Hemmila MR, Mattar A, Taddonio MA, Arbabi S, Hamouda T, Ward PA, Wang SC, Baker JR Jr,. Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury. Surgery 2010; 148: 499-509.
25. Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS,. Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm 2007; 341: 215-220.
26. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S,. Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnology 2008; 6: 8.
27. Nalbandian R, Henry R, Balko K, Adams D, Neuman N,. Pluronic F-127 gel preparation as an artificial skin in the treatment of third-degree burns in pigs. J Biomed Mater Res 1987; 21: 1135-1148.
28. DiBiase MD, Rhodes CT,. Investigations of epidermal growth factor in semisolid formulations. Pharm Acta Helv 1991; 66: 165-169.
29. O'Shaughnessy KD, De La Garza M, Roy NK, Mustoe TA,. Homeostasis of the epidermal barrier layer: a theory of how occlusion reduces hypertrophic scarring. Wound Repair Regen 2009; 17: 700-708.
30. Morris DE, Wu L, Zhao LL, Bolton L, Roth SI, Ladin DA, Mustoe TA,. Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 1997; 100: 674-681.
31. Rahmani-Neishaboor E, Jackson J, Burt H, Ghahary A,. Composite hydrogel formulations of stratifin to control MMP-1 expression in dermal fibroblasts. Pharm Res 2009; 26: 2002-2014.
32. USP 24. Sterilization and sterility assurance. US Pharmacopeia. 2001.
33. Tandara AA, Mustoe TA,. The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel. J Plast Reconstr Aesthet Surg 2008; 61: 1219-1225.
34. Tandara A, Mustoe T, Mogford J,. Impact of hydration on MMP activity. Wound Repair Regen 2008; 12: A6.
35. Kloeters O, Schierle C, Tandara A, Mustoe TA,. The use of a semiocclusive dressing reduces epidermal inflammatory cytokine expression and mitigates dermal proliferation and inflammation in a rat incisional model. Wound Repair Regen 2008; 16: 568-575.
36. Escobar-Chavez JJ, Lopez-Cervantes M, Naik A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A,. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006; 9: 339-358.
37. Bishop SM, Walker M, Rogers AA, Chen WY,. Importance of moisture balance at the wound-dressing interface. J Wound Care 2003; 12: 125-128.
38. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M,. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005; 124: 170-177.
39. Kloeters O, Tandara A, Mustoe TA,. Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 2007; 15 (Suppl. 1): S40-45.
40. Castagnoli C, Trombotto C, Ondei S, Stella M, Calcagni M, Magliacani G, Alasia ST,. Characterization of T-cell subsets infiltrating post-burn hypertrophic scar tissues. Burns 1997; 23: 565-572.